Response to the EZH2 inhibitor tazemetostat is independent of cell of origin determined via Hans imunohistochemistry or nanostring lymphoma subtyping test in EZH2 wild-type DLBCL patients Meeting Abstract
| Authors: | McDonald, A. A.; Morschhauser, F.; Ribrag, V.; McKay, P.; Salles, G.; Tilly, H.; Schmitt, A.; Gerecitano, J.; Dickinson, M. J.; Assouline, S.; Haioun, C.; Gribben, J. G.; Zinzani, P. L.; Wu, H.; Kussick, S.; Storhoff, J.; Larus, J.; Clawson, A.; Grayson, A.; Daigle, S.; Ho, P.; Miao, H.; Blakemore, S. |
| Abstract Title: | Response to the EZH2 inhibitor tazemetostat is independent of cell of origin determined via Hans imunohistochemistry or nanostring lymphoma subtyping test in EZH2 wild-type DLBCL patients |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419406378 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.2745.2745 |
| Notes: | Meeting Abstract: 2745 -- Source: Wos |
